2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)butanoic acid, 1g

1-Thiazol-5-yl-ethanone, 96.0%, 1g

N-Benzyloxycarbonyl-S-benzyl-L-cysteine>98.0%(HPLC)(T)5g

2-Acetoxy-3',4'-difluorobenzophenone, 90.0%, 1g

Tert-butyl (1-benzhydrylazetidin-3-yl)(methyl)carbamate, 98+%, 50g

N-[(1,1-Dimethylethoxy)carbonyl]-O-(1,1-dimethylethyl)-D-tyrosine, 97%, 25g

tert-Butyl octahydro-1H-pyrrolo[3,2-c]pyridine-1-carboxylate, 95.0%, 5g

1-Methylpiperidine-3-carboxylic acid hydrochloride, 98.0%, 10g

(2-Chloro-1H-benzo[d]imidazol-6-yl)methanol, 97.0%, 10g

3,4-Dichlorobenzotrichloride>98.0%(GC)500g

Electroporation cuvettes 450 µl 50 pcs

Pyrantel tartrate, 98.33%, 1g

2-METHYLCYCLOPENTANECARBOXYLIC ACID, 95.0%, 250mg